Randomized, controlled crossover study of IVIg for demyelinating polyneuropathy and diabetes

OBJECTIVE: To determine whether IV immunoglobulin (IVIg) is more effective than placebo at reducing disability in patients with diabetes and demyelinating polyneuropathy features. METHODS: This is a double-blinded, single-center, randomized, controlled crossover trial of IVIg treatment vs placebo. T...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Neurol Neuroimmunol Neuroinflamm
Egile Nagusiak: Breiner, Ari, Barnett Tapia, Carolina, Lovblom, Leif Erik, Perkins, Bruce A., Katzberg, Hans D., Bril, Vera
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Lippincott Williams & Wilkins 2019
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6943235/
https://ncbi.nlm.nih.gov/pubmed/31454771
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000586
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak